Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece
Summary Background & Aim The treatment of hepatitis C (HCV) with interferon (IFN)-free Direct-Acting Antivirals (DAAs) is anticipated to change the future burden of disease. Aim of this study is to quantify the impact of IFN-free DAAs on HCV-related morbidity and mortality in Greece under different scenarios concerning treatment coverage and primary prevention, including the […]
English 
Spanish 
French 
Russian 
Arabic